The Journal of Prolotherapy - For Doctors & Patients
OUR MISSION IS TO EDUCATE THE WORLD ON THE LIFE-CHANGING EFFECTS OF PROLOTHERAPY
back
1

 
A Retrospective Study on Dextrose Prolotherapy for Unresolved Knee Pain at an Outpatient Charity Clinic in Rural Illinois
 

 


The optimal long-term, symptomatic therapy for unresolved knee pain has not been established. Accordingly, we investigated the outcomes of patients undergoing Hackett-Hemwall dextrose Prolotherapy treatment for unresolved knee pain at a charity clinic in rural Illinois. We studied a sample of 80 patients, representing a total of 119 knees, that were treated quarterly with Prolotherapy. On average, 15 months following their last Prolotherapy session, patients were contacted and asked numerous questions in regard to their levels of pain and a variety of physical and psychological symptoms, as well as activities of daily living, before and after their last Prolotherapy treatment. The results of this study showed that patients had a statistically significant decline in their level of pain, stiffness, crunching sensation, and improvement in their range of motion with Prolotherapy. More than 82% showed improvements in walking ability, medication usage, athletic ability, anxiety, depression, and overall disability with Prolotherapy. Ninety-six percent of patients felt Prolotherapy improved their life overall. Conclusion: In this study, patients with unresolved knee pain, treated with dextrose Prolotherapy, showed improvements in many clinically relevant parameters and overall quality of life.


 


The optimal long-term, symptomatic therapy for unresolved knee pain has not been established. Accordingly, we investigated the outcomes of patients undergoing Hackett-Hemwall dextrose Prolotherapy treatment for unresolved knee pain at a charity clinic in rural Illinois. Knee pain is a common problem facing many patients, presenting in up to 20% of the adult population.1 Currently in the U.S., osteoarthritis of the knee results in chronic knee pain in approximately 17 million people.2 According to the American Academy of Orthopaedic Surgeons, between the years 1998 and 2005, the number of knee replacements doubled, resulting in an estimated 533,808 procedures done in the year 2005.3 By the year 2030, this number is projected to be 3.48 million.4 With this one form of surgery already accruing over $17 billion in hospitalization charges in 2005, and 90% of these needing to be repeated in 10 years, we suggest that the Hackett-Hemwall dextrose Prolotherapy technique for treating the injured knee is a safe, effective, and less expensive solution to a portion of this rising trend.5,6

Prolotherapy is becoming a widespread form of pain management in both complementary and allopathic medicine.7,8,9,10 Its primary use is in pain management associated with tendinopathies and ligament sprains in peripheral joints.11,12,13 Prolotherapy is also being used in the treatment of spine and joint degenerative arthritis.14,15 In double-blinded human studies, the evidence on the effectiveness of Prolotherapy has been considered promising, but mixed.16,17,18 Prolotherapy treatments are now done at some major medical centers and universities.19,20

George S. Hackett, MD, Prolotherapy pioneer, coined the term Prolotherapy in the 1930s.21 As he described it, “The treatment consists of the injection of a solution within the relaxed ligament and tendon which will stimulate the production of new fibrous tissue and bone cells that will strengthen the ‘weld’ of fibrous tissue and bone to stabilize the articulation and permanently eliminate the disability.”22 Animal studies have shown that Prolotherapy induces the production of new collagen by stimulating the normal inflammatory reaction.23,24 In addition, animal studies have shown improvements in ligament and tendon diameter and strength.25,26 Human studies have shown improvements in pain symptoms.27,28
back
1
 

Join Prolotherapy on Facebook Read Our Blog Bookmark and Share
Beulah Land PRESS • 715 LAKE ST • SUITE 600 • OAK PARK, IL 60301 • 708-848-5011
 
© 2011 The Journal of Prolotherapy is part of Beulah Land Corporation. To find a Prolotherapy doctor, or become listed as a Prolotherapy physician please visit www.getprolo.com. For further information on Prolotherapy please visit www.prolotherapy.org, or to learn more about our Editor-In-Chief, Ross Hauser, MD, please visit http://www.caringmedical.com/therapies/prolotherapy.asp or www.rosshauser.com.